ACTRN12620000793910
Completed
未知
Determining the efficacy of a new Prostate Cancer Screening Test combining Circulating Tumour Cells (CTC) and Prostate-Specific Markers: a population-study of 50-75 year old men
AProf Dr Karin Ried0 sites300 target enrollmentAugust 7, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- prostate cancer
- Sponsor
- AProf Dr Karin Ried
- Enrollment
- 300
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Men 50\-75 years old
- •Primary group 1: men not diagnosed with cancer
- •Group 2: men diagnosed with prostate cancer (Test will provide probability of relapse or tumour progression)
Exclusion Criteria
- •men diagnosed with other cancers
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Evaluation of therapeutic effect on prostate cancer patients with bone metastases using Bone Scan Index (BSI)Prostate cancer patients with bone metastasisJPRN-UMIN000011648Osaka University160
Recruiting
Not Applicable
Clinical study of prostate cancer dagnositic makers using genetic polymorphismsProstate cancerJPRN-UMIN000019278Kyoto University2,000
Not yet recruiting
Not Applicable
Evaluation of safety and efficacy in prostate cancer patients treated with focal low-dose-rate brachytherapyProstate cancerJPRN-UMIN000030509Kitasato University School of Medicine, Department of Urology20
Recruiting
Not Applicable
Detection of clinically significant prostate cancer with MRI-TRUS fusion image-guided biopsy: comparison of the evaluation system (PI-RADS category vs. PI-RADS + US evalutaion)Suspected prostate cancerJPRN-UMIN000050631Tokai University80
Completed
Not Applicable
The study of the treatment efficacy in prostate cancer with low dose abirateroneProstate cancerTCTR20211012001/A21